FDA Approved Drugs - Jan-Feb 2014
1. Dapagliflozin: For the treatment of type II diabetes, January of 2014
2. Metreleptin : For the treatment of congenital or acquired generalized lipodystrophy.
3. Droxidopa : For the treatment of neurogenic orthostatic hypotension
4. Elosulfase alfa : For the treatment of Mucopolysaccharidosis type IVA, Approved February 2014
5.Ibrutinib : For the treatment of chronic lymphocytic leukemia
6.Tasimelteon : For the treatment of non-24-hour sleep-wake disorder in the totally blind.
P.s Note : Miposmersen is an antisense therapeutic that targets the messenger RNA for apolipoprotein B and it is used for Homozygous familial hypercholesterolemia ( Once Weekly SC Injection , T1/2 30 days ) approved in JAN 2013 : Most Probable Question